U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

AbbVie

Market Cap: US$401.5b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$298.3b

Operates as a healthcare company worldwide.

Travere Therapeutics

Market Cap: US$4.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Mesa Laboratories

Market Cap: US$574.0m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Waters

Market Cap: US$35.9b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

BioLife Solutions

Market Cap: US$1.3b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Repligen

Market Cap: US$6.9b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Sotera Health

Market Cap: US$4.5b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Corcept Therapeutics

Market Cap: US$7.8b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.